JNL/Mellon Healthcare Sector Fund is a registered fund series of JNL Series Trust (series S000068125). Net assets $2.6B as of 2026-03-31. Index fund.
Showing 15 of 135 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Eli Lilly and Company | — | $313.8M | 1229.75% |
| Johnson & Johnson | — | $252.2M | 988.32% |
| AbbVie Inc. | — | $164.6M | 644.93% |
| Merck & Co., Inc. | — | $128.0M | 501.46% |
| UnitedHealth Group Incorporated | — | $105.1M | 411.86% |
| Amgen Inc. | — | $81.1M | 317.66% |
| Thermo Fisher Scientific Inc. | — | $79.1M | 310.17% |
| Abbott Laboratories | — | $76.5M | 299.83% |
| Gilead Sciences, Inc. | — | $74.1M | 290.42% |
| Intuitive Surgical, Inc. | — | $69.7M | 273.10% |
| Pfizer Inc. | — | $68.2M | 267.27% |
| Bristol-Myers Squibb Company | BMY | $52.9M | 207.27% |
| Danaher Corporation | — | $52.3M | 205.14% |
| Stryker Corporation | — | $50.9M | 199.43% |
| Vertex Pharmaceuticals Incorporated | — | $48.5M | 190.10% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $2.6B |
| 2025-12-31 | $2.8B |
| 2025-09-30 | $2.7B |
| 2025-06-30 | $2.7B |
| 2025-03-31 | $3.0B |
| 2024-12-31 | $2.9B |
| 2024-09-30 | $3.4B |
| 2024-06-30 | $3.3B |